NCT00975091 - Continue Entecavir Rollover From China | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Chronic Hepatitis B Virus

Interventions

DRUG

Entecavir

Tablets, Oral, 0.5 mg, once daily, Until ETV is commercially available in China or when Post Study Drug Program is started

DRUG

Entecavir

Tablets, Oral, 1.0 mg, once daily, Until ETV is commercially available in China or when Post Study Drug Program is started